| Literature DB >> 22201736 |
Regine Schneider-Stock1, Akram Ghantous, Khuloud Bajbouj, Melody Saikali, Nadine Darwiche.
Abstract
Epigenetic mechanisms are essential for normal development and maintenance of adult life. Disruption of epigenetic processes results in deregulated gene expression and leads to life-threatening diseases, in particular, cancer. Global epigenetic alterations are a hallmark of cancer. Cancer epigenetics revealed the deregulation of all components of the epigenetic machinery including DNA methylation, histone modifications, chromatin structure, and non-coding RNAs. Drugs targeting epigenetic processes, or "epi-drugs", are at the forefront of drug discovery, and plant-derived compounds have shown promise. Most of the plant-derived anticancer drugs that work through epigenetic mechanisms are polyphenols; the others are alkaloids, organosulfur compounds, and terpenoids. This review focuses on the epigenetic machinery and its basis for cancer therapy, highlights plant-derived anticancer drugs with epigenetic mechanisms of action, and discusses their potential use in epigenetic therapy.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22201736 DOI: 10.2741/3919
Source DB: PubMed Journal: Front Biosci (Landmark Ed) ISSN: 2768-6698